Operating income Revenue 350.8 million GBP (2013) | Founded 1959 Headquarters Abingdon, United Kingdom Subsidiaries Andor Technology | |
 | ||
Industry Top level markets include research and academia, industry, energy, environment, security, health Key people Alan Thomson (Chairman)Ian Barkshire (CEO) Products AnalysersAtomic force microscopesCoating thickness measurement analysersCryogenic systemsCT & MRI systems, maintenance & partsElectron spectroscopesMicroanalysis systemsNanomanipulation & nanofabricationPlasma, ALD & ion beamScanning probe microscopesSpectrometersSuperconducting magnets and wireThin film & tailored UHV systemsX-ray tubes and integrated sources Stock price OXIG (LON) 793.19 GBX +8.69 (+1.11%)28 Mar, 4:51 PM GMT+1 - Disclaimer CEO Ian Barkshire (11 May 2016–) Profiles | ||
Careers at oxford instruments plasma technology
Oxford Instruments plc is a United Kingdom manufacturing and research company that designs and manufactures tools and systems for industry and research. The company is headquartered in Abingdon, Oxfordshire, England, with sites in the United Kingdom, United States, Europe, and Asia. It is listed on the London Stock Exchange.
Contents
- Careers at oxford instruments plasma technology
- Oxford instruments the business of science
- History
- Activities
- References
Oxford instruments the business of science
History
The company was founded by Sir Martin Wood in 1959 with help from his wife Audrey, to manufacture superconducting magnets for use in scientific research, starting in his garden shed in Northmoor Road, Oxford, England. It was the first substantial commercial spin-out company from the University of Oxford and was first listed on the London Stock Exchange in 1983.
It had a pioneering role in the development of magnetic resonance imaging, providing the first superconducting magnets for this application. The first commercial MRI whole body scanner was manufactured at its Osney Mead factory in Oxford in 1980 for installation at Hammersmith Hospital, London. Further innovations included the development of active shielding, whereby fringe fields hazardous to pacemaker wearers, causing difficulty and expense in siting, were virtually eliminated.
Oxford Instruments was not able to capitalise on these inventions itself, granting royalty-free licence to Philips and General Electric whilst developing a joint venture with Siemens in 1989: this was dissolved in 2004.